SCMP
Sucampo Pharmaceuticals, Inc.
SCMP
SCMP
Delisted
SCMP was delisted on the 12th of February, 2018.
178 hedge funds and large institutions have $360M invested in Sucampo Pharmaceuticals, Inc. in 2017 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 68 increasing their positions, 48 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
178
Holders Change
+11
Holders Change %
+6.59%
% of All Funds
4.44%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
30
Increased
68
Reduced
48
Closed
17
Calls
$1.19M
Puts
$309K
Net Calls
+$884K
Net Calls Change
-$358K
Top Buyers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$22M |
| 2 |
Goldman Sachs
New York
|
+$7.52M |
| 3 |
LCM
Laurion Capital Management
New York
|
+$7.33M |
| 4 |
Renaissance Technologies
New York
|
+$5.84M |
| 5 |
Prudential Financial
Newark,
New Jersey
|
+$4.34M |
Top Sellers
| 1 |
RCMNY
Rubric Capital Management (New York)
New York
|
-$4.44M |
| 2 |
Millennium Management
New York
|
-$2.74M |
| 3 |
HHC
Hutchin Hill Capital
New York
|
-$1.2M |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$1.03M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$1M |
